PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 185 filers reported holding PTC THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $20,412,277 | +376.6% | 421,393 | +275.6% | 0.28% | +387.7% |
| Q4 2022 | $4,282,712 | -89.1% | 112,201 | -85.6% | 0.06% | -89.6% |
| Q3 2022 | $39,183,000 | +298.8% | 780,537 | +218.2% | 0.55% | +262.9% |
| Q2 2022 | $9,825,000 | +26.3% | 245,260 | +17.6% | 0.15% | +19.8% |
| Q1 2022 | $7,779,000 | -63.6% | 208,493 | -61.1% | 0.13% | -58.8% |
| Q4 2021 | $21,347,000 | +2.5% | 535,944 | -4.3% | 0.31% | -10.0% |
| Q3 2021 | $20,830,000 | +43.5% | 559,794 | +63.0% | 0.34% | +25.5% |
| Q2 2021 | $14,518,000 | +17.2% | 343,451 | +31.3% | 0.27% | -1.5% |
| Q1 2021 | $12,384,000 | +68.4% | 261,534 | +117.1% | 0.28% | +41.0% |
| Q4 2020 | $7,352,000 | -46.3% | 120,471 | -58.8% | 0.20% | -56.5% |
| Q3 2020 | $13,680,000 | +48.4% | 292,610 | +61.0% | 0.45% | +22.7% |
| Q2 2020 | $9,220,000 | -12.2% | 181,710 | -22.8% | 0.36% | -51.3% |
| Q1 2020 | $10,496,000 | -31.1% | 235,286 | -25.8% | 0.75% | +20.6% |
| Q4 2019 | $15,236,000 | – | 317,226 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
| Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
| ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
| COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
| GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
| SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
| Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
| Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |